mMe: Motivational Monitoring to Enhance Smoking Cessation Among Cancer Patients
mMe
Motivational Monitoring to Enhance Smoking Cessation Among Cancer Patients Pilot Study
1 other identifier
observational
25
1 country
1
Brief Summary
The objectives of this study are to pilot test a protocol of weekly assessments of motivation to quit and other relevant constructs combined with information about how to enroll in cessation programs, which will allow initial quantification of motivation to quit during cancer treatment and develop hypotheses about the impact of motivation on the decision to enroll in services.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Jul 2022
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 27, 2022
CompletedFirst Posted
Study publicly available on registry
May 12, 2022
CompletedStudy Start
First participant enrolled
July 18, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 13, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
February 13, 2024
CompletedApril 3, 2024
April 1, 2024
1.6 years
April 27, 2022
April 1, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
Number of participants who enroll in cessation services
Assessed using administrative records
12 weeks after study start
Secondary Outcomes (3)
Level of and change in motivation and self-efficacy to quit smoking
Through study completion, an average of 12 weeks
Level of and change in anxiety and depression
Through study completion, an average of 12 weeks
Number of smoking quit attempts
12 weeks after study start
Study Arms (1)
Mme Study Participants
Participants will complete a baseline survey, 11 weekly surveys, and a follow-up survey at 12 weeks
Interventions
There is no intervention or exposure for this study
Eligibility Criteria
Patients being seen at the study recruitment sites for cancer treatment, who have a current cancer diagnosis and who are currently smoking. Other concurrent tobacco use is also acceptable.
You may qualify if:
- An adult (18+)
- Current smoker defined by: Has smoked 100 cigarettes in their lifetime (may be multi-tobacco users as long as they also use combustible cigarettes).
- Any type of cancer (except non-melanoma skin cancer)
- Anticipates receiving any of the following cancer treatments in the 3 months following enrollment: chemotherapy, surgery, immunotherapy, bone marrow or stem cell transplant, hormone therapy, or radiation
- Access to the Internet
You may not qualify if:
- Not smoked 100 cigarettes in their lifetime
- \< 18 years in age
- Diagnosed with non-melanoma skin cancer
- Not diagnosed with cancer
- Does not anticipate receiving cancer treatments in the 3 months following enrollment
- Has been previously enrolled in an existing Cancer Center Tobacco Treatment Program (TTP)
- Not comfortable reading and responding to questions in English
- No consistent access to the Internet
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Virginia Cancer Center and affiliated sites
Charlottesville, Virginia, 22908, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Research Assistant Professor of Public Health Sciences
Study Record Dates
First Submitted
April 27, 2022
First Posted
May 12, 2022
Study Start
July 18, 2022
Primary Completion
February 13, 2024
Study Completion
February 13, 2024
Last Updated
April 3, 2024
Record last verified: 2024-04